Glaxo Wellcome earmarks more for research

April 17, 1998

Pharmaceutical giant Glaxo Wellcome spent Pounds 1.15 billion on research and development in 1997, according to its annual report. The firm, which notched up global sales worth Pounds 8 billion, says it expects to spend Pounds 1.2 billion on R&D next year. It says that for the pharmaceutical industry worldwide, sales in 1997 were up 9 per cent to Pounds 166 billion.The North American market saw the greatest increase from 9 per cent growth in 1996 to 15 per cent in 1997, generating Pounds 61 billion of sales.

The United States accounts for 35 per cent of the global market. Europe has experienced a decline in growth from 9 per cent to 6 per cent. Growth in Latin America has increased from 7 per cent to 11 per cent, while in Asia Pacific growth has slowed from 13 per cent to 9 per cent.

Already registered?

Sign in now if you are already registered or a current subscriber. Or subscribe for unrestricted access to our digital editions and iPad and iPhone app.

Have your say

Log in or register to post comments

Featured Jobs

Library Systems Manager YORK ST JOHN UNIVERSITY
Chair in Law UNIVERSITY OF BRISTOL (MAIN OFFICE)
User Acceptance Testing Technician CAMBRIDGE ASSESSMENT

Register to continue  

You've enjoyed reading five THE articles this month. Register now to get five more, or subscribe for unrestricted access.

Most Commented

Globalisation

Times Higher Education World University Rankings data reveal the top 200 most outward-looking institutions

Common cactus finch (Geospiza scandens)

Tiffany Taylor on a thought-provoking view of the forces acting to ensure survival

Stressed businessman answering four telephones

Some surveys show faculty putting in at least 60 hours a week, but research casts doubt on whether this is a productive routine

Student asking question during class

University of Reading research finds link between undergraduate satisfaction and ethnicity of lecturers

Level of quality compass

Authors argue this means universities should spend less on senior academics and give promising younger scholars more of a chance